NIVF

NewGenIvf Group Ltd NIVF

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $23.7M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$4.73M

Quarter to Dec 31

Net income

$9.88M

Quarter to Dec 31

Free cash flow

$-11.06M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$44.1K total
Clear Street Group Inc.
$11.7K0.0%
MMCAP International Inc. SPC
$11.3K0.0%
Mint Tower Capital Management B.V.
$5.0K0.0%
Walleye Trading LLC
$4.9K0.0%
D. E. Shaw & Co., Inc.
$4.2K0.0%
RIVERNORTH CAPITAL MANAGEMENT, LLC
$2.8K0.0%
TORONTO DOMINION BANK
$1.5K0.0%
PERISCOPE CAPITAL INC.
$1.2K0.0%
CITADEL ADVISORS LLC
$705-3.9%
Mariner, LLC
$5650.0%
WOLVERINE ASSET MANAGEMENT LLC
$287-11.2%
See all 11 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

NIVF key financials by period

Reported revenue, net income and operating margin by fiscal year, from NewGenIvf Group Ltd's annual filings on SEC EDGAR.

NewGenIvf Group Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$4.7M$9.9M—
FY 2024$5.4M$-524.6K-21.4%
FY 2023$5.1M$130.2K0.8%
FY 2022$5.9M$458.7K6.7%
FY 2021$4.1M$-533.004.8%
Source: NIVF filings on SEC EDGAR →

NIVF insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About NewGenIvf Group Ltd (NIVF): stock profile, AI score and financials

NewGenIvf Group Ltd (NIVF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NIVF is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $23.7m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), NewGenIvf Group Ltd reports quarterly revenue of $4.7M, net income of $9.9M, free cash flow of $-11.1M. Top institutional holders of NIVF by reported 13-F value include Clear Street Group, MMCAP International SPC, Mint Tower Capital Management B.V., based on the most recent SEC filings. NIVF trades on the Nasdaq exchange and files with the SEC under CIK 1981662. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NIVF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NewGenIvf Group Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1981662 →